Background: Dyslipidemia is considered as an important modifiable risk factor for
cardiovascular disease (CVD). The link between childhood dyslipidemia and occurrence of …

Dyslipidemia is seen with increasing prevalence in young Canadians, mainly mild to
moderate hypertriglyceridemia secondary to obesity. This review focuses on pediatric …

Background Statins are currently the preferred pharmacological therapy in individuals with
familial hypercholesterolemia (FH) with the aim to prevent premature atherosclerosis. In …

Dyslipidemia, the disorder of lipoprotein metabolism resulting in high lipid profile, is an
important modifiable risk factor for coronary heart diseases. It is associated with more than …

Background The objectives of this study were to determine the longer‐term trends in
childhood obesity and hyperlipidemia among residents of Fukushima Prefecture 5 years …

Objectives To characterize lipids and lipoproteins in a diverse school-based cohort and
identify features associated with discordance between low-density lipoprotein cholesterol …

Amplia y universalmente documentada, por sus complicaciones la obesidad es una
epidemia con fuertes repercusiones en salud y en costos. En 2006-2007 la OMS propuso …

METHOD: This guideline will be developed and reported according to the format of the
World Health Organization (WHO) Handbook for Guideline Development. All members of the …

Цель. Оценить распространенность и клинико-лабораторные проявления
неалкогольной жировой болезни печени (НАЖБП) у детей с избыточной массой тела и …

Background Oxidized low density lipoprotein (oxLDL), anti-oxLDL antibodies (oxLDL Ab)
and lipoprotein-associated phospholipase A2 (Lp-PLA2) are the sequel of lipoprotein …